Immersive Virtual Reality vs Treadmill Exercise Project
NCT07213388, Not applicable, Completed, Rowan University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Immersive Virtual Reality vs Treadmill Exercise Project | ClinicalTrials.gov |
| NCT number | NCT07213388 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 61 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Rowan University | ClinicalTrials.gov |
| Conditions | Control, Virtual Reality Physical Activity, Treadmill | ClinicalTrials.gov |
| Interventions | VRPA, Treadmill, Control | ClinicalTrials.gov |
| First posted | 2025-10-08 | ClinicalTrials.gov |
| Last updated | 2026-01-16 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Pace of participant recruitment | Up to 24 months | enrollment rate of 6 participants per month | ClinicalTrials.gov |
| Primary | Number of participants willing to continue using the assigned exercie modality | Day 1 | Willingness to continue using the exercise modality to which the participants were assigned and self-report enjoyment from engaging in the assigned exercise. | ClinicalTrials.gov |
| Primary | Percentage of participants who complete the required tasks in each condition | Day 1 | Are participants able to complete the required tasks | ClinicalTrials.gov |
| Secondary | Changes in Heart Rate | Day 1 | Differences in heart rate from pre- to post session | ClinicalTrials.gov |
| Secondary | Self-reported measures of "flow" associated with the assigned conditions | Day 1 | Flow will be assessed using the Flow Short Scale (Rheinberg et al, 2003) that is comprised of 13 questions answered on a 7-point scale (1 = Not at all, 7 = very much). Scores can range from 13-91, with lower scores indicating less of a "flow state" or feelings of immersion in the assigned activity. | ClinicalTrials.gov |
| Secondary | Changes in affect | Day 1 | Using the Activation-Deactivation Checklist (Thayer et al., 1986), participants will rate 20 different adjectives on a 4-point scale (1= definitely feel, 2= feel slightly, 3= cannot decide, 4= definitely do not feel) before they engage in the assigned activity and after they engage in the assigned activity. Lower numbers will indicate higher endorsements of a particular feeling, but the primary outcome will examine any changes in pre- to post-activity ratings of the different affective states. | ClinicalTrials.gov |
| Secondary | Rate of percieved exertion | Day 1 | Borg's Rate of Perceived Exertion will be used to measure how participants rate their perceived exertion on a scale of 6 (no exertion at all) to 20 (maximal exertion) (Borg, 1982). The scale is anchored to the participant's subjective perception, with descriptors such as "extremely hard." Rate of perceived exertion will be evaluated post-activity only and will be compared across groups. | ClinicalTrials.gov |
| Secondary | Changes in Stroop Color and Word Test | Day 1 | The Stroop Color and Word Test (Golden et al, 2002) will be conducted pre- and post-assigned activities. Raw scores (e.g., reaction times, errors) will be calculated and changes in those scores from pre- to post-activity will be determined. | ClinicalTrials.gov |
| Secondary | Number of Calories Burned | Day 1 | Total number of calories burned during the assigned condition | ClinicalTrials.gov |
| Secondary | Number of Active Minutes | Day 1 | Total number of active minutes during the assigned condition | ClinicalTrials.gov |
| Secondary | Changes in Executive Functioning | Day 1 | The Trail Making Test (TMT) will be used to calculate changes in executive function (Arbuthnott \& Frank, 2000; Kortte et al., 2002; Reitan, 1956). Participants will be required to draw lines connecting different scattered numbers (Part A) and scattered numbers and letters (Part B). If the test can not be completed in 5-minutes it will be stopped. The more errors a person makes, and the longer a person takes, indicate poorer outcomes for executive function and changes in this measure will be calculated from pre- to post-activity. | ClinicalTrials.gov |
| Secondary | Changes in Working Memory Capacity | Day 1 | The Backward Digits Span (BDT, Lamar et al., 2007) measures an individual's working memory capacity and is comprised of 21 trials where participants will need to recall 3, 4, and 5-digit spans. The more numbers a person can correctly recall the better their working memory. Changes in this measure, from pre- to post-activity, will be calculated | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)